ArticleMethodsX2025
Transcranial magnetic stimulation combined with mindfulness for pain and disability management in migraine patients: a protocol feasibility study.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Migraine is the second leading cause of disability worldwide, contributing to high healthcare costs, reduced work productivity, and diminished quality of life. Non-pharmacological therapies such as repetitive transcranial magnetic stimulation (rTMS) and mindfulness-based practices (MBPs) have independently demonstrated effectiveness in reducing headache frequency and medication use, offering safer and more tolerable alternatives to pharmacological treatments. This study aims to evaluate the feasibility of a randomized controlled trial (RCT) combining rTMS and MBPs for the management of pain and disability in women with chronic migraine. This double-blind, parallel-group, randomized protocol will include 24 participants assigned in a 1:1 ratio to either a sham group (sham rTMS + mindfulness) or an active intervention group (rTMS + mindfulness). Each participant will undergo eight sessions over four weeks, with assessments conducted at baseline and 30-day follow-up. Outcomes will include measures of pain, disability, mindfulness, anxiety, depression, acceptability, adherence, and safety, collected through validated questionnaires and session logs. In this trial, participants, outcome assessors, and data analysts will be blinded to group allocation. Due to the nature of the intervention, therapists administering rTMS cannot be blinded. Thus, the study is defined as double-blind rather than triple-blind. Feasibility outcomes will include recruitment and retention rates, protocol compliance, randomization and blinding success, and occurrence of adverse events. The results will inform the design of a larger-scale RCT. Given the potential of both rTMS and mindfulness in migraine treatment, their combination may lead to meaningful improvements in symptom management and quality of life in individuals with chronic migraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.